Further, in the many areas without access to viral load testing, CD4+ counts are often used to assess the success of cART, and the decision to commence or change opportunistic infection (OI) prophylaxis invariably requires CD4+ counts. This evidence concerns the gene CD4 and Opportunistic infection.